Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 4Gastritis, Atrophic 2Carcinoma, Hepatocellular 2Barrett Esophagus 2Stomach Ulcer 1Lymphoma, Mantle-Cell 1Gastrointestinal Neoplasms 1Gastrointestinal Hemorrhage 1Gastrointestinal Diseases 1Gastritis 1Fibrosis 1Colorectal Neoplasms 1Cholangiocarcinoma 1Adenomatous Polyposis Coli 1Adenocarcinoma Of Esophagus 1

Interventions

Specimen Handling 2Colonoscopy 2Biopsy 2trifluridine tipiracil drug combination 1Sigmoidoscopy 1Oxaliplatin 1Nivolumab 1Leucovorin 1Gastroscopy 1Fluorouracil 1Exercise Therapy 1Endoscopy, Gastrointestinal 1Endoscopy, Digestive System 1Celecoxib 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Adenomatous Polyposis Coli × Endoscopy, Digestive System × Clear all
NCT06557733 2026-05-13

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

National Cancer Institute (NCI)

Phase 2 Recruiting
38 enrolled
Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡